April 2008 Volume 5 Number 4
Visit Nature Clinical Practice Oncology online to browse the journal.
Now available at http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0UgF0Er
=====================================================================
ESO e-grandround - http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPN0ED
The European School of Oncology in partnership with Nature Clinical Practice
Oncology is pleased to announce live e-grandrounds. These online
discussion-based presentations allow participants to submit questions and
take part in lively discussions. We invite you to join the e-grandrounds,
which are broadcast every other Thursday from 17:15-18:00 GMT.
Please visit http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0Boj10E6
for further information.
=====================================================================
----------------------
EDITORIAL
----------------------
Strong inference
Vincent T DeVita Jr
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPO0EE
----------------------
VIEWPOINT
----------------------
Artificial ultraviolet sources and skin cancers: rationale for restricting
access to sunbed use before 18 years of age
Philippe Autier and Peter Boyle
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPP0EF
----------------------
RESEARCH HIGHLIGHTS
----------------------
TP53 mutation is associated with poor survival in patients with head
and neck cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPQ0EG
Stroma-specific TP53 alterations correlate with clinical outcome in
breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPR0EH
Capecitabine and oxaliplatin are effective treatments in advanced
esophagogastric cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPS0EI
Chemoradiotherapy: standard treatment for Hodgkin's disease with favorable
prognosis
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPT0EJ
Prognostic value of pretreatment quality of life in patients with head
and neck cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPU0EK
Adjuvant chemotherapy improves outcome in women with estrogen-receptor-poor
breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPV0EL
HER2 status affects responsiveness to adjuvant anthracyclines
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPW0EM
Letrozole is superior to tamoxifen for endocrine-responsive breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPX0EN
Lymphocyte-predominant Hodgkin's lymphoma: patient characteristics and
outcomes
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPY0EO
----------------------
PRACTICE POINTS
----------------------
Is total thyroidectomy the procedure of choice for papillary thyroid
cancer?
Robert Udelsman
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPZ0EP
Bevacizumab in combination with irinotecan for patients with recurrent
glioblastoma multiforme
David Schiff and Benjamin Purow
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPa0EW
What is the relevance of determining EGFR-variant-III status in
glioblastomas?
Antonio MP Omuro
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPb0EX
A comparison of chemotherapy plus surgery with surgery alone for localized
esophageal cancer
Dirk Rades and Steven E Schild
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPc0EY
Is trastuzumab associated with adverse cardiac effects in patients with
breast cancer?
Michael S Ewer and Daniel J Lenihan
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPd0EZ
----------------------
REVIEWS
----------------------
Angiogenesis as a strategic target for ovarian cancer therapy
Whitney A Spannuth, Anil K Sood and Robert L Coleman
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPe0Ea
Metastasis: a therapeutic target for cancer
Patricia S Steeg and Dan Theodorescu
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPf0Eb
Technology Insight: water diffusion MRI-a potential new biomarker
of response to cancer therapy
Daniel M Patterson, Anwar R Padhani and David J Collins
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPg0Ec
----------------------
CASE STUDY
----------------------
Methotrexate-associated mantle-cell lymphoma in an elderly man with
myasthenia gravis
Huy Tran, Catherine Cheung, Devinder Gill, Ujjwal Dua, Jamie Nourse,
Richard Boyle and Maher K Gandhi
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPh0Ed
----------------------
ARTICLE RESPONSE
----------------------
Sentinel lymph-node false positivity in melanoma
Alexander CJ van Akkooi, Johannes HW de Wilt, Christiane Voit,
Cees Verhoef, Stefan Suciu and Alexander MM Eggermont
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BrPi0Ee
=====================================================================
Access the #1 journal in Dermatology*
The Journal of Investigative Dermatology features timely, peer-reviewed
contributions highlighting experimental, theoretical, and clinical aspects
in cutaneous biology and skin disease. Recommend a site license to your
librarian by visiting
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0BSup0Er
and gain access to the leading journal in dermatology.
*Rank 1/39 Dermatology, Journal Citation Reports, Thomson, 2007
=====================================================================
You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/ejxs0Xztnp0HjM0Zzu0E3
(You will need to log in to be recognised as a nature.com registrant).
For further technical assistance, please contact our registration department:
registration@nature.com
For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com
For other enquiries, please contact our customer feedback department:
feedback@nature.com
Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA
Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston
=====================================================================
